Folia Parasitologica 72:002 (2025) | DOI: 10.14411/fp.2025.002

Special Issue: Toxoplasma gondii, suicidal behaviour and suicide risk factors in US Veterans enrolled in mental health treatment

Teodor T. Postolache ORCID...1-4, 14, *, Erica Duncan ORCID...5, 6, 14, Poyu Yen4, Eileen Potocki7, Meghan Barnhart1, Amanda Federline2, Nicholas Massa ORCID...5, Aline Dagdag4, Joshua Joseph ORCID...4, Abhishek Wadhawan ORCID...4, 8, Colt D. Capan9, Cameron Forton9, Christopher A. Lowry ORCID...1, 3, 10, Heidi K. Ortmeyer11, 12, Lisa A. Brenner ORCID...1, 3, 13, 14
1 Veterans Health Administration, Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Veterans Integrated Service Network (VISN) 19, Aurora, CO, USA;
2 Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Integrated Service Network (VISN) 5, VA Capitol Health Care Network, Baltimore, MD, USA;
3 Military and Veteran Microbiome: Consortium for Research and Education (MVM-CoRE), Aurora, CO, USA;
4 Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA;
5 Atlanta Veterans Affairs Health Care System, Decatur, GA, USA;
6 Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, USA;
7 VA Maryland Healthcare System, Baltimore VA Medical Center, Baltimore, MD, USA;
8 Saint Elizabeths Hospital, Department of Psychiatry, Washington, DC, USA;
9 Department for Neurodegenerative Sciences, Van Andel Research Institute, Grand Rapids, MI, USA;
10 Department of Integrative Physiology and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA;
11 Baltimore VA Medical Center, Baltimore, MD, USA;
12 Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;
13 Departments of Physical Medicine and Rehabilitation, Psychiatry and Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
14 Share senior authorship *Address for correspondence: Teodor T. Postolache, MD; 685 West Baltimore Street, MSTF Building, Room 930 Baltimore, MD 21201, USA

Markers of chronic infection Toxoplasma gondii (Nicolle et Manceaux, 1908) have been associated with suicidal self-directed violence (SSDV). We present the results of the first study relating T. gondii IgG serology with suicide attempts and suicidal ideation in United States Veterans, known to have higher suicide rates than members of the general population. We also related T. gondii serology to SSDV risk factors, including valid and reliable measures of trait impulsivity, aggression, self-reported depression, and sleep disturbance. We recruited 407 Veterans enrolled at three Veterans Affairs Medical Centers with mean (S.D.) age = 45.6 (11.6) years; 304 men (74.7%); 203 with a history of SSDV and 204 with no history of any self-directed violence (SDV). Seropositivity and serointensity, categorised as high (top quartile) or low (lower three quartiles), were analysed in relationship to SSDV, suicidal ideation and clinical risk factors using age and gender-adjusted linear and logistic methods, after transformations and nonparametric tests when appropriate. Associations between seropositivity and SSDV and its risk factors were not significant in all groups. High serointensity, while not associated with SSDV or repeat suicide attempts, was positively associated with suicidal ideation, depression, impulsivity, and daytime dysfunction due to sleepiness (p < 0.05), but only in Veterans with a history of SSDV. In Veterans without a history of SDV, no associations were significant. These associations remained significant after adjustment for certain socioeconomic factors (i.e., income, homelessness, military rank). Including education in the model downgraded the statistical significance of suicidal ideation and depression to statistical trends, but the significance of associations with impulsivity and daytime dysfunction due to sleepiness remained. Major limitations include the cross-sectional design, overall low seropositivity within the sample, and potentially spurious results due to multiple comparisons. Thus, the results of this report need to be replicated in larger samples, ideally longitudinally.

Keywords: depression, suicidality, impulsivity, sleep impairment, United States

Received: September 1, 2024; Revised: October 20, 2024; Accepted: October 21, 2024; Published online: January 9, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Postolache, T.T., Duncan, E., Yen, P., Potocki, E., Barnhart, M., Federline, A., ... Brenner, L.A. (2025). Special Issue: Toxoplasma gondii, suicidal behaviour and suicide risk factors in US Veterans enrolled in mental health treatment. Folia Parasitologica72, Article 2025.002. https://doi.org/10.14411/fp.2025.002


This article is part of Special Issue,  Effects of Latent Toxoplasmosis: Three Decades of Studies.


LMm_stahnout_citaci

References

  1. Afonso C., Paixão V.B., Costa R.M. 2012: Chronic Toxoplasma infection modifies the structure and the risk of host behavior. PLoS One 7: e32489. Go to original source... Go to PubMed...
  2. Ahmad Z., Moustafa Y.W., Stiller J.W., Pavlovich M.A., Raheja U.K., Gragnoli C., Snitker S., Nazem S., Dagdag A., Fang B., Fuchs D., Lowry C.A., Postolache T.T. 2017: Sleep onset insomnia, daytime sleepiness and sleep duration in relationship to Toxoplasma gondii IgG seropositivity and serointensity. Pteridines 28: 195-204. Go to original source... Go to PubMed...
  3. Alter S., Wilson C., Sun S., Harris R.E., Wang Z., Vitale A., Hazlett E.A., Goodman M., Ge Y., Yehuda R., Galfalvy H., Haghighi F. 2021: The association of childhood trauma with sleep disturbances and risk of suicide in US Veterans. J. Psychiatr. Res. 136: 54-62. Go to original source... Go to PubMed...
  4. Alvarado-Esquivel C., Carrillo-Oropeza D., Pacheco-Vega S.J., Hernández-Tinoco J., Salcedo-Jaquez M., Sánchez-Anguiano L.F., Ortiz-Jurado M.N., Alarcón-Alvarado Y., Liesenfeld O., Beristain-García I. 2015: Toxoplasma gondii exposure in patients suffering from mental and behavioral disorders due to psychoactive substance use. BMC Infect. Dis. 15: 172. Go to original source... Go to PubMed...
  5. Alvarado-Esquivel C., Estrada-Martínez S., Pérez-Álamos A.R., Ramos-Nevárez A., Botello-Calderón K., Alvarado-Félix Á O., Vaquera-Enríquez R., Alvarado-Félix G.A., Sifuentes-Álvarez A., Guido-Arreola C.A., Rábago-Sánchez E., Saenz-Soto L. 2022: Toxoplasma gondii infection and insomnia: a case control seroprevalence study. PLoS One 17: e0266214. Go to original source... Go to PubMed...
  6. Alvarado-Esquivel C., Estrada-Martínez S., Ramos-Nevárez A., Pérez-Álamos A.R., Beristain-García I., Alvarado-Félix Á O., Cerrillo-Soto S.M., Sifuentes-Álvarez A., Alvarado-Félix G.A., Guido-Arreola C.A., Saenz-Soto L. 2021: Association between Toxoplasma gondii exposure and suicidal behavior in patients attending primary health care clinics. Pathogens 10: 677 Go to original source... Go to PubMed...
  7. Alvarado-Esquivel C., Martínez-Martínez A.L., Sánchez-Anguiano L.F., Hernández-Tinoco J., Castillo-Orona J.M., Salas-Martínez C., Sifuentes-Álvarez A., Sandoval-Carrillo A.A., Salas-Pacheco J.M., Liesenfeld O., Antuna-Salcido E.I. 2017: Lack of association between Toxoplasma gondii exposure and depression in pregnant women: a case-control study. BMC Infect. Dis. 17: 190. Go to original source... Go to PubMed...
  8. Alvarado-Esquivel C., Sanchez-Anguiano L.F., Hernandez-Tinoco J., Berumen-Segovia L.O., Torres-Prieto Y.E., Estrada-Martinez S., Perez-Alamos A.R., Ortiz-Jurado M.N., Molotla-de-Leon G., Beristain-Garcia I., Rabago-Sanchez E., Liesenfeld O. 2016: Toxoplasma gondii infection and depression: a case-control seroprevalence study. Eur. J. Microbiol. Immunol. 6: 85-89. Go to original source... Go to PubMed...
  9. American Psychiatric Association 2013: Diagnostic and statistical manual of mental disorders, (DSM-5®). American Psychiatric Pub. Go to original source...
  10. Amminger G.P., McGorry P.D., Berger G.E., Wade D., Yung A.R., Phillips L.J., Harrigan S.M., Francey S.M., Yolken R.H. 2007: Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol. Psychiatry 61: 1215-1217. Go to original source... Go to PubMed...
  11. Amouei A., Moosazadeh M., Nayeri Chegeni T., Sarvi S., Mizani A., Pourasghar M., Hosseini Teshnizi S., Hosseininejad Z., Dodangeh S., Pagheh A., Pourmand A.H., Daryani A. 2020: Evolutionary puzzle of Toxoplasma gondii with suicidal ideation and suicide attempts: an updated systematic review and meta-analysis. Transbound. Emerg. Dis. 67: 1847-1860. Go to original source... Go to PubMed...
  12. Arling T.A., Yolken R.H., Lapidus M., Langenberg P., Dickerson F.B., Zimmerman S.A., Balis T., Cabassa J.A., Scrandis D.A., Tonelli L.H., Postolache T.T. 2009: Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 197: 905-908. Go to original source... Go to PubMed...
  13. Arnau R.C., Meagher M.W., Norris M.P., Bramson R. 2001: Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol. 20: 112-119. Go to original source... Go to PubMed...
  14. Asgari Q., Motazedian M.H., Khazanchin A., Mehrabani D., Naderi Shahabadi S. 2021: High prevalence of Toxoplasma gondii infection in type I diabetic patients. J. Parasitol. Res. 2021: 8881908. Go to original source... Go to PubMed...
  15. de Barros J.L., Barbosa I.G., Salem H., Rocha N.P., Kummer A., Okusaga O.O., Soares J.C., Teixeira A.L. 2017: Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J. Affect Disord. 209: 59-65. Go to original source... Go to PubMed...
  16. Beck A.T., Steer R.A., Ball R., Ranieri W. 1996: Comparison of Beck depression inventories -IA and -II in psychiatric outpatients. J. Pers. Assess. 67: 588-597. Go to original source... Go to PubMed...
  17. Beck A., Steer R., Ranieri W. 1993: Scale for suicide ideation: psychometric properties of a self-report version. J. Clin. Psychol. 44: 499-505. Go to original source...
  18. Benros M.E., Waltoft B.L., Nordentoft M., Ostergaard S.D., Eaton W.W., Krogh J., Mortensen P.B. 2013: Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70: 812-820. Go to original source... Go to PubMed...
  19. Berenreiterová M., Flegr J., Kuběna A.A., Němec P. 2011: The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 6: e28925. Go to original source... Go to PubMed...
  20. Bernert R.A., Kim J.S., Iwata N.G., Perlis M.L. 2015: Sleep disturbances as an evidence-based suicide risk factor. Curr. Psychiatry Rep. 17: 554. Go to original source... Go to PubMed...
  21. Bogner J., Corrigan J.D. 2009: Reliability and predictive validity of the Ohio State University TBI identification method with prisoners. J. Head Trauma Rehabil. 24: 279-291. Go to original source... Go to PubMed...
  22. Bortolato M., Shih J.C. 2011: Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int. Rev. Neurobiol. 100: 13-42. Go to original source... Go to PubMed...
  23. Bovin M.J., Marx B.P., Weathers F.W., Gallagher M.W., Rodriguez P., Schnurr P.P., Keane T.M. 2016: Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in Veterans. Psychol. Assess. 28: 1379-1391. Go to original source... Go to PubMed...
  24. Bramoweth A.D., Germain A. 2013: Deployment-related insomnia in military personnel and Veterans. Curr. Psychiatry Rep. 15: 401. Go to original source... Go to PubMed...
  25. Brooks J.M., Carrillo G.L., Su J., Lindsay D.S., Fox M.A., Blader I.J. 2015: Toxoplasma gondii infections alter GABAergic synapses and signaling in the central nervous system. mBio 6: e01428-01415. Go to original source... Go to PubMed...
  26. Brown A.S., Schaefer C.A., Quesenberry C.P. Jr., Liu L., Babulas V.P., Susser E.S. 2005: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 162: 767-773. Go to original source... Go to PubMed...
  27. Brundin L., Erhardt S., Bryleva E.Y., Achtyes E.D., Postolache T.T. 2015: The role of inflammation in suicidal behaviour. Acta Psychiatr. Scand. 132: 192-203. Go to original source... Go to PubMed...
  28. Brundin L., Sellgren C.M., Lim C.K., Grit J., Pålsson E., Landén M., Samuelsson M., Lundgren K., Brundin P., Fuchs D., Postolache T.T., Traskman-Bendz L., Guillemin G.J., Erhardt S. 2016: An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation. Transl. Psychiatry 6: e865. Go to original source... Go to PubMed...
  29. Burgdorf K.S., Trabjerg B.B., Pedersen M.G., Nissen J., Banasik K., Pedersen O.B., Sørensen E., Nielsen K.R., Larsen M.H., Erikstrup C., Bruun-Rasmussen P., Westergaard D., Thørner L.W., Hjalgrim H., Paarup H.M., Brunak S., Pedersen C.B., Torrey E.F., Werge T., Mortensen P.B., Yolken R.H., Ullum H. 2019: Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders. Brain Behav. Immun. 79: 152-158. Go to original source... Go to PubMed...
  30. Buss A.H., Perry M. 1992: The aggression questionnaire. J. Pers. Soc. Psychol. 63: 452-459. Go to original source... Go to PubMed...
  31. Buysse D.J., Reynolds C.F. 3rd, Monk T.H., Berman S.R., Kupfer D.J. 1989: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28: 193-213. Go to original source... Go to PubMed...
  32. Centers for Disease Control and Prevention 2023: Suicide data and statistics. April 10 2024, https://www.cdc.gov/suicide/facts/data.html.
  33. Chester D.S., DeWall C.N., Derefinko K.J., Estus S., Lynam D.R., Peters J.R., Jiang Y. 2016: Looking for reward in all the wrong places: dopamine receptor gene polymorphisms indirectly affect aggression through sensation-seeking. Soc. Neurosci. 11: 487-494. Go to original source... Go to PubMed...
  34. Cho H.J., Savitz J., Dantzer R., Teague T.K., Drevets W.C., Irwin M.R. 2017: Sleep disturbance and kynurenine metabolism in depression. J. Psychosom. Res. 99: 1-7. Go to original source... Go to PubMed...
  35. Coccaro E.F., Lee R., Groer M.W., Can A., Coussons-Read M., Postolache T.T. 2016: Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J. Clin. Psychiatry 77: 334-341. Go to original source... Go to PubMed...
  36. Cohen D.A., Wang W., Wyatt J.K., Kronauer R.E., Dijk D.J., Czeisler C.A., Klerman E.B. 2010: Uncovering residual effects of chronic sleep loss on human performance. Sci. Transl. Med. 2: 14ra3. Go to original source... Go to PubMed...
  37. Cook R.D., Weisberg S. 2009: An Introduction to Regression Graphics, John Wiley & Sons, New York, 280 pp.
  38. Cook T.B., Brenner L.A., Cloninger C.R., Langenberg P., Igbide A., Giegling I., Hartmann A.M., Konte B., Friedl M., Brundin L., Groer M.W., Can A., Rujescu D., Postolache T.T. 2015: "Latent" infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J. Psychiatr. Res. 60: 87-94. Go to original source... Go to PubMed...
  39. Cornaby C., Gibbons L., Mayhew V., Sloan C.S., Welling A., Poole B.D. 2015: B cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol. Lett. 163: 56-68. Go to original source... Go to PubMed...
  40. Corona C.C., Zhang M., Wadhawan A., Daue M.L., Groer M.W., Dagdag A., Lowry C.A., Hoisington A.J., Ryan K.A., Stiller J.W., Fuchs D., Mitchell B.D., Postolache T.T. 2019: Toxoplasma gondii IgG associations with sleep-wake problems, sleep duration and timing. Pteridines 30: 1-9. Go to original source... Go to PubMed...
  41. Corrigan J.D., Bogner J. 2007: Initial reliability and validity of the Ohio State University TBI Identification Method. J. Head Trauma Rehabil. 22: 318-329. Go to original source... Go to PubMed...
  42. Coryell W., Wilcox H., Evans S.J., Pandey G.N., Jones-Brando L., Dickerson F., Yolken R. 2020: Latent infection, inflammatory markers and suicide attempt history in depressive disorders. J. Affect Disord. 270: 97-101. Go to original source... Go to PubMed...
  43. Cusick M.F., Libbey J.E., Fujinami R.S. 2012: Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev.Allergy Immunol. 42: 102-111. Go to original source... Go to PubMed...
  44. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. 2008: Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 165: 59-65. Go to original source... Go to PubMed...
  45. Dickerson F., Wilcox H.C., Adamos M., Katsafanas E., Khushalani S., Origoni A., Savage C., Schweinfurth L., Stallings C., Sweeney K., Yolken R. 2017: Suicide attempts and markers of immune response in individuals with serious mental illness. J. Psychiatr Res. 87: 37-43. Go to original source... Go to PubMed...
  46. Dubey J.P., Jones J.L. 2008: Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38: 1257-1278. Go to original source... Go to PubMed...
  47. Duffy A.R., Beckie T.M., Brenner L.A., Beckstead J.W., Seyfang A., Postolache T.T., Groer M.W. 2015: Relationship between Toxoplasma gondii and mood disturbance in women Veterans. Mil. Med. 180: 621-625. Go to original source... Go to PubMed...
  48. Dumais A., Lesage A.D., Alda M., Rouleau G., Dumont M., Chawky N., Roy M., Mann J.J., Benkelfat C., Turecki G. 2005: Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 162: 2116-2124. Go to original source... Go to PubMed...
  49. Dupont D., Lin J.S., Peyron F., Akaoka H., Wallon M. 2021: Chronic Toxoplasma gondii infection and sleep-wake alterations in mice. CNS Neurosci. Ther. 27: 895-907. Go to original source... Go to PubMed...
  50. Dwivedi Y. 2012: The Neurobiological Basis of Suicide. CRC Press, Boca Raton, 482 pp. Go to original source...
  51. Dwivedi Y. 2018: MicroRNAs in depression and suicide: recent insights and future perspectives. J. Affect. Disord. 240: 146-154. Go to original source... Go to PubMed...
  52. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E.R., Nemanov L., Katz M., Belmaker R.H. 1996: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat. Genet. 12: 78-80. Go to original source... Go to PubMed...
  53. Erhardt S., Lim C.K., Linderholm K.R., Janelidze S., Lindqvist D., Samuelsson M., Lundberg K., Postolache T.T., Träskman-Bendz L., Guillemin G.J., Brundin L. 2013: Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38: 743-752. Go to original source... Go to PubMed...
  54. Ernst C., Mechawar N., Turecki G. 2009: Suicide neurobiology. Progr. Neurobiol. 89: 315-333. Go to original source... Go to PubMed...
  55. Fallon B.A., Madsen T., Erlangsen A., Benros M.E. 2021: Lyme borreliosis and associations with mental disorders and suicidal behavior: a nationwide Danish cohort study. Am. J. Psychiatry 178: 921-931. Go to original source... Go to PubMed...
  56. Fang I., Tooley D., Gatewood C., Renegar K.B., Majde J.A., Krueger J.M. 1996: Differential effects of total and upper airway influenza viral infection on sleep in mice. Sleep 19: 337-342.
  57. Fekadu A., Shibre T., Cleare A.J. 2010: Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms. Folia Parasitol. 57: 105-113. Go to original source... Go to PubMed...
  58. Flegr J., Chvátalová V., Příplatová L., Tureček P., Kodym P., ©ebánková B., Kaňková ©. 2024: Cognitive effects of Toxoplasma and CMV infections: a cross-sectional study of 557 young adults considering modulation by sex and Rh factor. Pathogens 13: 363. Go to original source... Go to PubMed...
  59. Flegr J., Escudero D.Q. 2016: Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects - an explorative cross-sectional study. Parasitology 143: 1974-1989. Go to original source... Go to PubMed...
  60. Flegr J., Havlícek J., Kodym P., Malý M., Smahel Z. 2002: Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2: 11. Go to original source... Go to PubMed...
  61. Flegr J., Hodný Z. 2016: Cat scratches, not bites, are associated with unipolar depression-cross-sectional study. Parasit. Vectors 9: 8. Go to original source... Go to PubMed...
  62. Flegr J., Kodym P., Tolarová V. 2000: Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol. Psychol. 53: 57-68. Go to original source... Go to PubMed...
  63. Flegr J., Zitková S., Kodym P., Frynta D. 1996: Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113: 49-54. Go to original source... Go to PubMed...
  64. Forehand J.A., Dufort V., Gradus J.L., Maguen S., Watts B.V., Jiang T., Holder N., Shiner B. 2022: Association between post-traumatic stress disorder severity and death by suicide in US military Veterans: retrospective cohort study. Br. J. Psychiatry: 1-7. Go to original source... Go to PubMed...
  65. Frank S.A. 2002: Specificity and cross-reactivity. In: S.A. Frank (Ed.), Immunology and Evolution of Infectious Disease. Princeton University Press, Princeton, pp. 33-56. Go to original source...
  66. Frickel E.M., Hunter C.A. 2021: Lessons from Toxoplasma: host responses that mediate parasite control and the microbial effectors that subvert them. J. Exp. Med. 218: e20201314. Go to original source... Go to PubMed...
  67. Fuller Torrey E., Rawlings R., Yolken R.H. 2000: The antecedents of psychoses: a case-control study of selected risk factors. Schizophr. Res. 46: 17-23. Go to original source... Go to PubMed...
  68. Gale S.D., Berrett A.N., Brown B., Erickson L.D., Hedges D.W. 2016: No association between current depression and latent toxoplasmosis in adults. Folia Parasitol. 63: 032. Go to original source... Go to PubMed...
  69. Gale S.D., Brown B.L., Berrett A., Erickson L.D., Hedges D.W. 2014: Association between latent toxoplasmosis and major depression, generalised anxiety disorder and panic disorder in human adults. Folia Parasitol. 61: 285-292. Go to original source...
  70. Gaskell E.A., Smith J.E., Pinney J.W., Westhead D.R., McConkey G.A. 2009: A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 4: e4801. Go to original source... Go to PubMed...
  71. Gilbert K.S., Kark S.M., Gehrman P., Bogdanova Y. 2015: Sleep disturbances, TBI and PTSD: implications for treatment and recovery. Clin. Psychol. Rev. 40: 195-212. Go to original source... Go to PubMed...
  72. Gjervig Hansen H., Köhler-Forsberg O., Petersen L., Nordentoft M., Postolache T.T., Erlangsen A., Benros M.E. 2019: Infections, anti-infective agents, and risk of deliberate self-harm and suicide in a young cohort: a nationwide study. Biol. Psychiatry 85: 744-751. Go to original source... Go to PubMed...
  73. von Glischinski M., von Brachel R., Hirschfeld G. 2019: How depressed is "depressed"? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II). Qual. Life Res. 28: 1111-1118. Go to original source... Go to PubMed...
  74. Gould C.E., Karna R., Jordan J., Kawai M., Hirst R., Hantke N., Pirog S., Cotto I., Schussler-Fiorenza Rose S.M., Beaudreau S.A., O'Hara R. 2018a: Subjective but not objective sleep is associated with subsyndromal anxiety and depression in community-dwelling older adults. Am. J. Geriatr. Psychiatry 26: 806-811. Go to original source... Go to PubMed...
  75. Gould C.E., Spira A.P., Liou-Johnson V., Cassidy-Eagle E., Kawai M., Mashal N., O'Hara R., Beaudreau S.A. 2018b: Association of anxiety symptom clusters with sleep quality and daytime sleepiness. J. Gerontol. B Psychol. Sci. Soc. Sci. 73: 413-420. Go to original source... Go to PubMed...
  76. Gould T.D., Georgiou P., Brenner L.A., Brundin L., Can A., Courtet P., Donaldson Z.R., Dwivedi Y., Guillaume S., Gottesman, II, Kanekar S., Lowry C.A., Renshaw P.F., Rujescu D., Smith E.G., Turecki G., Zanos P., Zarate C.A., Jr., Zunszain P.A., Postolache T.T. 2017: Animal models to improve our understanding and treatment of suicidal behavior. Transl. Psychiatry 7: e1092. Go to original source... Go to PubMed...
  77. Grant I.H., Gold J.W., Rosenblum M., Niedzwiecki D., Armstrong D. 1990: Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4: 519-521. Go to original source...
  78. Groer M.W., Yolken R.H., Xiao J.C., Beckstead J.W., Fuchs D., Mohapatra S.S., Seyfang A., Postolache T.T. 2011: Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am. J. Obstet. Gynecol. 204: 433.e1-433.e7. Go to original source... Go to PubMed...
  79. Hamdani N., Daban-Huard C., Lajnef M., Richard J.R., Delavest M., Godin O., Le Guen E., Vederine F.E., Lepine J.P., Jamain S., Houenou J., Le Corvoisier P., Aoki M., Moins-Teisserenc H., Charron D., Krishnamoorthy R., Yolken R., Dickerson F., Tamouza R., Leboyer M. 2013: Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J. Affect Disord. 148: 444-448. Go to original source... Go to PubMed...
  80. Havlíček J., Gaąová Z.G., Smith A.P., Zvára K., Flegr J. 2001: Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology 122: 515-520. Go to original source... Go to PubMed...
  81. Hawton K. 1987: Assessment of suicide risk. Br. J. Psychiatry 150: 145-53. Go to original source... Go to PubMed...
  82. van Heeringen K., Mann J.J. 2014: The neurobiology of suicide. Lancet Psychiatry 1: 63-72. Go to original source... Go to PubMed...
  83. Hinze-Selch D., Daubener W., Erdag S., Wilms S. 2010: The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol. 57: 129-135. Go to original source... Go to PubMed...
  84. Hou Z., Wang L., Su D., Cai W., Zhu Y., Liu D., Huang S., Xu J., Pan Z., Tao J. 2022: Global microRNAs expression profile analysis reveals possible regulatory mechanisms of brain injury induced by Toxoplasma gondii infection. Front. Neurosci. 16: 827570. Go to original source... Go to PubMed...
  85. Huertas-López A., Cantos-Barreda A., Sánchez-Sánchez R., Martínez-Carrasco C., Ibáñez-López F.J., Martínez-Subiela S., Cerón J.J., Álvarez-García G. 2024: A systematic review and meta-analysis of the validation of serological methods for detecting anti-Toxoplasma gondii antibodies in humans and animals. Vet. Parasitol. 328: 110173. Go to original source... Go to PubMed...
  86. Javelle F., Bloch W., Knoop A., Guillemin G.J., Zimmer P. 2021: Toward a neuroprotective shift: eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive humans a randomized controlled trial. Brain. Behav. Immun. 96: 7-17. Go to original source... Go to PubMed...
  87. Joiner Jr T.E., Van Orden K.A. 2008: The interpersonal-psychological theory of suicidal behavior indicates specific and crucial psychotherapeutic targets. Int. J. Cogn. Ther. 1: 80-89. Go to original source...
  88. Kamal A.M., Kamal A.M., Abd El-Fatah A.S., Rizk M.M., Hassan E.E. 2022: Latent toxoplasmosis is associated with depression and suicidal behavior. Arch. Suicide Res. 26: 819-830. Go to original source... Go to PubMed...
  89. Keilp J.G., Gorlyn M., Russell M., Oquendo M.A., Burke A.K., Harkavy-Friedman J., Mann J.J. 2013: Neuropsychological function and suicidal behavior: attention control, memory and executive dysfunction in suicide attempt. Psychol. Med. 43: 539-551. Go to original source... Go to PubMed...
  90. Keilp J.G., Sackeim H.A., Brodsky B.S., Oquendo M.A., Malone K.M., Mann J.J. 2001: Neuropsychological dysfunction in depressed suicide attempters. Am. J. Psychiatry 158: 735-741. Go to original source... Go to PubMed...
  91. Khademvatan S., Izadi-Mazidi M., Saki J., Khajeddin N. 2016: Mental health and latent toxoplasmosis: comparison of individuals with and without anti-Toxoplasma antibodies. World Health Popul. 17: 39-46. Go to original source... Go to PubMed...
  92. Köhler-Forsberg O., Petersen L., Gasse C., Mortensen P.B., Dalsgaard S., Yolken R.H., Mors O., Benros M.E. 2019: A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry 76: 271-279. Go to original source... Go to PubMed...
  93. Laing C., Blanchard N., McConkey G.A. 2020: Noradrenergic signaling and neuroinflammation crosstalk regulate Toxoplasma gondii-induced behavioral changes. Trends Immunol. 41: 1072-1082. Go to original source... Go to PubMed...
  94. Lee E.E., Amritwar A., Hong L.E., Mohyuddin I., Brown T., Postolache T.T. 2020: Daily and seasonal variation in light exposure among the old order Amish. Int. J. Environ. Res. Public Health. 17: 4460. Go to original source... Go to PubMed...
  95. Lee Y.J., Kim S., Gwak A.R., Kim S.J., Kang S.G., Na K.S., Son Y.D., Park J. 2016: Decreased regional gray matter volume in suicide attempters compared to suicide non-attempters with major depressive disorders. Compr. Psychiatry 67: 59-65. Go to original source... Go to PubMed...
  96. Li Y., Viscidi R.P., Kannan G., McFarland R., Pletnikov M.V., Severance E.G., Yolken R.H., Xiao J. 2018: Chronic Toxoplasma gondii infection induces anti-N-methyl-d-aspartate receptor autoantibodies and associated behavioral changes and neuropathology. Infect. Immun. 86: e00398-18. Go to original source... Go to PubMed...
  97. Li Z., Lei Z., Yang W., Jing C., Sun X., Yang G., Zhao X., Zhang M., Xu M., Tang Y., Wang Q., Zhao J., Zhou Z., Wen Z., Chen X., Peng Q., Wang G., Zhang P., Sun E., Shen N., Xu W., Li Z., Yang H., Yin Z. 2024: Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus. Parasit. Vectors 17: 44. Go to original source... Go to PubMed...
  98. Lima T.S., Lodoen M.B. 2019: Mechanisms of human innate immune evasion by Toxoplasma gondii. Front Cell Infect. Microbiol. 9: 103. Go to original source... Go to PubMed...
  99. Lindová J., Kuběna A.A., ©turcová H., Křivohlavá R., Novotná M., Rubeąová A., Havlíček J., Kodym P., Flegr J. 2010: Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol. 57: 136-142. Go to original source...
  100. Lindová J., Novotná M., Havlíček J., Jozífková E., Skallová A., Kolbeková P., Hodný Z., Kodym P., Flegr J. 2006: Gender differences in behavioural changes induced by latent toxoplasmosis. Int. J. Parasitol. 36: 1485-1492. Go to original source... Go to PubMed...
  101. Linehan M.M., Comtois K.A., Brown M.Z., Heard H.L., Wagner A. 2006: Suicide Attempt Self-Injury Interview (SASII): development, reliability, and validity of a scale to assess suicide attempts and intentional self-injury. Psychol. Assess 18: 303-312. Go to original source... Go to PubMed...
  102. Linehan M.M., Comtois K.A., Ward-Ciesielski E.F. 2012: Assessing and managing risk with suicidal individuals. Cogn. Behav. Pract. 19: 218-232. Go to original source...
  103. Liu X., Liu Z.Z., Wang Z.Y., Yang Y., Liu B.P., Jia C.X. 2019: Daytime sleepiness predicts future suicidal behavior: a longitudinal study of adolescents. Sleep 42: zsy225. Go to original source...
  104. Lund-Sørensen H., Benros M.E., Madsen T., Sørensen H.J., Eaton W.W., Postolache T.T., Nordentoft M., Erlangsen A. 2016: A nationwide cohort study of the association between hospitalization with infection and risk of death by suicide. JAMA Psychiatry 73: 912-919. Go to original source... Go to PubMed...
  105. Lutz P.E., Mechawar N., Turecki G. 2017: Neuropathology of suicide: recent findings and future directions. Mol. Psychiatry 22: 1395-1412. Go to original source... Go to PubMed...
  106. Malloy-Diniz L.F., Lage G.M., Campos S.B., de Paula J.J., de Souza Costa D., Romano-Silva M.A., de Miranda D.M., Correa H. 2013: Association between the catechol O-methyltransferase (COMT) Val158met polymorphism and different dimensions of impulsivity. PLoS One 8: e73509. Go to original source... Go to PubMed...
  107. Mann J.J. 1998: The neurobiology of suicide. Nat. Med. 4: 25-30. Go to original source... Go to PubMed...
  108. Mann J.J., Arango V.A., Avenevoli S., Brent D.A., Champagne F.A., Clayton P., Currier D., Dougherty D.M., Haghighi F., Hodge S.E., Kleinman J., Lehner T., McMahon F., Moscicki E.K., Oquendo M.A., Pandey G.N., Pearson J., Stanley B., Terwilliger J., Wenzel A. 2009: Candidate endophenotypes for genetic studies of suicidal behavior. Biol. Psychiatry 65: 556-563. Go to original source... Go to PubMed...
  109. Mann J.J., Waternaux C., Haas G.L., Malone K.M. 1999: Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry 156: 181-189. Go to original source... Go to PubMed...
  110. Markon A.O., Ryan K.A., Wadhawan A., Pavlovich M., Groer M.W., Punzalan C., Gensheimer K., Jones J., Daue M.L., Dagdag A., Donnelly P., Peng X., Pollin T., Mitchell B.D., Postolache T.T. 2020: Risk factors for Toxoplasma gondii seropositivity in the Old Order Amish. Epidemiol. Infect. 149: e89. Go to original source... Go to PubMed...
  111. Martin H.L., Alsaady I., Howell G., Prandovszky E., Peers C., Robinson P., McConkey G.A. 2015: Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells. Neuroscience 306: 50-62. Go to original source... Go to PubMed...
  112. Maruani J., Molière F., Godin O., Yrondi A., Bennabi D., Richieri R., El-Hage W., Allauze E., Anguill L., Bouvard A., Camus V., Dorey J.M., Etain B., Fond G., Genty J.B., Haffen E., Holtzmann J., Horn M., Kazour F., Nguon A.S., Petrucci J., Rey R., Stephan F., Vaiva G., Walter M., Lejoyeux M., Leboyer M., Llorca P.M., Courtet P., Aouizerate B., Geoffroy P.A. 2023: Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: a 1-year prospective study about sleep markers. J. Affect Disord. 329: 369-378. Go to original source... Go to PubMed...
  113. Massa N.M., Duncan E., Jovanovic T., Kerley K., Weng L., Gensler L., Lee S.S., Norrholm S., Powers A., Almli L.M., Gillespie C.F., Ressler K., Pearce B.D. 2017: Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population. Brain Behav. Immun. 61: 176-183. Go to original source... Go to PubMed...
  114. McConkey G.A., Martin H.L., Bristow G.C., Webster J.P. 2013: Toxoplasma gondii infection and behaviour - location, location, location? J. Exp. Biol. 216: 113-119. Go to original source... Go to PubMed...
  115. Meers S., Lagrou K., Theunissen K., Dierickx D., Delforge M., Devos T., Janssens A., Meersseman W., Verhoef G., Van Eldere J., Maertens J. 2010: Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clin. Infect. Dis. 50: 1127-1134. Go to original source... Go to PubMed...
  116. Meshreky K.M., Wood J., Chowdari K.V., Hall M.H., Wilckens K.A., Yolken R., Buysse D.J., Nimgaonkar V.L. 2019: Infection with Herpes Simplex Virus type 1 (HSV-1) and sleep: the dog that did not bark. Psychiatry Res. 280: 112502. Go to original source... Go to PubMed...
  117. Mitra R., Sapolsky R.M., Vyas A. 2013: Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion. Dis. Model Mech. 6: 516-520.
  118. Monti J.M. 2011: Serotonin control of sleep-wake behavior. Sleep Med. Rev. 15: 269-281. Go to original source... Go to PubMed...
  119. Mortensen P.B., Norgaard-Pedersen B., Waltoft B.L., Sorensen T.L., Hougaard D., Torrey E.F., Yolken R.H. 2007: Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 61: 688-693. Go to original source... Go to PubMed...
  120. Münz C., Lünemann J.D., Getts M.T., Miller S.D. 2009: Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9: 246-258. Go to original source... Go to PubMed...
  121. Nicolle C., Manceaux L. 1908 Sur une infection à corps de Leishman (ou organismes voisins) du gondi. C. R. Acad. Sci. 147: 763-766
  122. Nicolle C., Manceaux L. 1909. Sur un protozoaire nouveau du Gondi. C. R. Acad. Sci. 148: 369-372.
  123. Niebuhr D.W., Millikan A.M., Cowan D.N., Yolken R., Li Y., Weber N.S. 2008: Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am. J. Psychiatry 165: 99-106. Go to original source... Go to PubMed...
  124. Nissen J., Trabjerg B., Pedersen M.G., Banasik K., Pedersen O.B., Sørensen E., Nielsen K.R., Erikstrup C., Petersen M.S., Paarup H.M., Bruun-Rasmussen P., Westergaard D., Hansen T.F., Pedersen C.B., Werge T., Torrey F., Hjalgrim H., Mortensen P.B., Yolken R., Brunak S., Ullum H., Burgdorf K.S. 2019: Herpes Simplex Virus Type 1 infection is associated with suicidal behavior and first registered psychiatric diagnosis in a healthy population. Psychoneuroendocrinology 108: 150-154. Go to original source... Go to PubMed...
  125. Notarangelo F.M., Wilson E.H., Horning K.J., Thomas M.A., Harris T.H., Fang Q., Hunter C.A., Schwarcz R. 2014: Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. Schizophr. Res. 152: 261-267. Go to original source... Go to PubMed...
  126. Nutt D., Wilson S., Paterson L. 2008: Sleep disorders as core symptoms of depression. Dialogues Clin. Neurosci. 10: 329-336. Go to original source... Go to PubMed...
  127. Okusaga O., Langenberg P., Sleemi A., Vaswani D., Giegling I., Hartmann A.M., Konte B., Friedl M., Groer M.W., Yolken R.H., Rujescu D., Postolache T.T. 2011b: Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr. Res. 133: 150-155. Go to original source... Go to PubMed...
  128. Okusaga O., Yolken R.H., Langenberg P., Lapidus M., Arling T.A., Dickerson F.B., Scrandis D.A., Severance E., Cabassa J.A., Balis T., Postolache T.T. 2011a: Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J. Affect. Disord. 130: 220-225. Go to original source... Go to PubMed...
  129. Olivadoti M.D., Weinberg J.B., Toth L.A., Opp M.R. 2011: Sleep and fatigue in mice infected with murine gammaherpesvirus 68. Brain Behav. Immun. 25: 696-705. Go to original source... Go to PubMed...
  130. Oliveira J., Kazma R., Le Floch E., Bennabi M., Hamdani N., Bengoufa D., Dahoun M., Manier C., Bellivier F., Krishnamoorthy R., Deleuze J.F., Yolken R., Leboyer M., Tamouza R. 2016: Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study. Int. J. Bipolar. Disord. 4: 11. Go to original source... Go to PubMed...
  131. Oquendo M.A., Sullivan G.M., Sudol K., Baca-Garcia E., Stanley B.H., Sublette M.E., Mann J.J. 2014: Toward a biosignature for suicide. Am. J. Psychiatry 171: 1259-1277. Go to original source... Go to PubMed...
  132. Owens M.J., Nemeroff C.B. 1994: Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40: 288-295. Go to original source...
  133. Pandey G.N. 2013: Biological basis of suicide and suicidal behavior. Bipolar Disord. 15: 524-541. Go to original source... Go to PubMed...
  134. Pappas G., Roussos N., Falagas M.E. 2009: Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39: 1385-1394. Go to original source... Go to PubMed...
  135. Parlog A., Schlüter D., Dunay I.R. 2015: Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 37: 159-170. Go to original source... Go to PubMed...
  136. Patton J.H., Stanford M.S., Barratt E.S. 1995: Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 51: 768-774. Go to original source...
  137. Pearce B.D., Kruszon-Moran D., Jones J.L. 2012: The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry 72: 290-295. Go to original source... Go to PubMed...
  138. Pedersen M.G., Mortensen P.B., Norgaard-Pedersen B., Postolache T.T. 2012: Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psychiatry 69: 1123-1130. Go to original source... Go to PubMed...
  139. Pedersen M.G., Stevens H., Pedersen C.B., Nørgaard-Pedersen B., Mortensen P.B. 2011: Toxoplasma infection and later development of schizophrenia in mothers. Am. J. Psychiatry 168: 814-821. Go to original source... Go to PubMed...
  140. Pigeon W.R., Britton P.C., Ilgen M.A., Chapman B., Conner K.R. 2012: Sleep disturbance preceding suicide among Veterans. Am. J. Public. Health 102: S93-S97. Go to original source... Go to PubMed...
  141. Plumb T.R., Peachey J.T., Zelman D.C. 2014: Sleep disturbance is common among servicemembers and Veterans of Operations Enduring Freedom and Iraqi Freedom. Psychol. Serv. 11: 209-219. Go to original source... Go to PubMed...
  142. Poirotte C., Kappeler P.M., Ngoubangoye B., Bourgeois S., Moussodji M., Charpentier M.J. 2016: Morbid attraction to leopard urine in Toxoplasma-infected chimpanzees. Curr. Biol. 26: R98-99. Go to original source... Go to PubMed...
  143. Porras-Segovia A., Pérez-Rodríguez M.M., López-Esteban P., Courtet P., Barrigón M.M., López-Castromán J., Cervilla J.A., Baca-García E. 2019: Contribution of sleep deprivation to suicidal behaviour: a systematic review. Sleep Med. Rev. 44: 37-47. Go to original source... Go to PubMed...
  144. Prandovszky E., Gaskell E., Martin H., Dubey J.P., Webster J.P., McConkey G.A. 2011: The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 6: e23866. Go to original source... Go to PubMed...
  145. Radon K., Dressel H., Windstetter D., Reichert J., Schmid M., Nowak D. 2003: Toxoplasma gondii infection, atopy and autoimmune disease. Eur. J. Med. Res. 8: 147-153.
  146. Retz W., Rösler M., Supprian T., Retz-Junginger P., Thome J. 2003: Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J. Neural. Transm. 110: 561-572. Go to original source... Go to PubMed...
  147. Ribeiro J.D., Pease J.L., Gutierrez P.M., Silva C., Bernert R.A., Rudd M.D., Joiner T.E. Jr. 2012: Sleep problems outperform depression and hopelessness as cross-sectional and longitudinal predictors of suicidal ideation and behavior in young adults in the military. J. Affect. Disord. 136: 743-750. Go to original source... Go to PubMed...
  148. Rivera-Correa J., Rodriguez A. 2018: Divergent roles of antiself antibodies during infection. Trends Immunol. 39: 515-522. Go to original source... Go to PubMed...
  149. Rojas M., Restrepo-Jiménez P., Monsalve D.M., Pacheco Y., Acosta-Ampudia Y., Ramírez-Santana C., Leung P.S.C., Ansari A.A., Gershwin M.E., Anaya J.M. 2018: Molecular mimicry and autoimmunity. J. Autoimmun. 95: 100-123. Go to original source... Go to PubMed...
  150. Saklayen S.S., Mabrouk O.S., Pehek E.A. 2004: Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J. Pharmacol. Exp. Ther. 311: 342-348. Go to original source... Go to PubMed...
  151. Sala-Hamrick K.J., Braciszewski J.M., Yeh H.H., Zelenak L., Westphal J., Beebani G., Frank C., Simon G.E., Owen-Smith A.A., Rossom R.C., Lynch F., Lu C.Y., Waring S.C., Harry M.L., Beck A., Daida Y.G., Ahmedani B.K. 2023: Diagnosed posttraumatic stress disorder and other trauma-associated stress disorders and risk for suicide mortality. Psychiatr. Serv. 74: 936-942. Go to original source... Go to PubMed...
  152. Salem D.A., Al-Ghamdi A.H., Alghamdi J.M., Ismail A., Alghamdi B.A., Abdelrazek E. 2023: Toxoplasma and Toxocara seropositivity in juvenile idiopathic arthritis and its relation to disease activity and type of therapies. Food Waterborne Parasitol. 31: e00195. Go to original source... Go to PubMed...
  153. Shapira Y., Agmon-Levin N., Selmi C., Petríková J., Barzilai O., Ram M., Bizzaro N., Valentini G., Matucci-Cerinic M., Anaya J.M., Katz B.S., Shoenfeld Y. 2012: Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J. Autoimmun. 39: 112-116. Go to original source... Go to PubMed...
  154. Shepard C.A., Rufino K.A., Lee J., Tran T., Paddock K., Wu C., Oldham J.M., Mathew S.J., Patriquin M.A. 2023: Nighttime sleep quality and daytime sleepiness predicts suicide risk in adults admitted to an inpatient psychiatric hospital. Behav. Sleep. Med. 21: 129-141. Go to original source... Go to PubMed...
  155. Shim C.H., Cho S., Shin Y.M., Choi J.M. 2022: Emerging role of bystander T cell activation in autoimmune diseases. BMB Rep. 55: 57-64. Go to original source... Go to PubMed...
  156. Skallová A., Kodym P., Frynta D., Flegr J. 2006: The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133: 525-535. Go to original source... Go to PubMed...
  157. Slater G., Steier J. 2012: Excessive daytime sleepiness in sleep disorders. J. Thorac. Dis. 4: 608-616.
  158. Söderholm J.J., Socada J.L., Rosenström T.H., Ekelund J., Isometsä E. 2023: Borderline personality disorder and depression severity predict suicidal outcomes: a six-month prospective cohort study of depression, bipolar depression, and borderline personality disorder. Acta Psychiatr. Scand. 148: 222-232. Go to original source... Go to PubMed...
  159. Soleymani E., Faizi F., Heidarimoghadam R., Davoodi L., Mohammadi Y. 2020: Association of T. gondii infection with suicide: a systematic review and meta-analysis. BMC Public Health 20: 766. Go to original source... Go to PubMed...
  160. Stibbs H.H. 1985: Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann. Trop. Med. Parasitol. 79: 153-157. Go to original source... Go to PubMed...
  161. Sublette M.E., Galfalvy H.C., Fuchs D., Lapidus M., Grunebaum M.F., Oquendo M.A., Mann J.J., Postolache T.T. 2011: Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav. Immun. 25: 1272-1278. Go to original source... Go to PubMed...
  162. Sutterland A.L., Fond G., Kuin A., Koeter M.W., Lutter R., van Gool T., Yolken R., Szoke A., Leboyer M., de Haan L. 2015: Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr. Scand. 132: 161-179. Go to original source... Go to PubMed...
  163. Sutterland A.L., Kuin A., Kuiper B., van Gool T., Leboyer M., Fond G., de Haan L. 2019: Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents - a systematic review and meta-analysis. Psychol. Med. 49: 1608-1623. Go to original source... Go to PubMed...
  164. Suvisaari J., Torniainen-Holm M., Lindgren M., Härkänen T., Yolken R.H. 2017: Toxoplasma gondii infection and common mental disorders in the Finnish general population. J. Affect Disord. 223: 20-25. Go to original source... Go to PubMed...
  165. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. 1986: Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry 21: 23-33. Go to original source... Go to PubMed...
  166. Tariq S.H., Tumosa N., Chibnall J.T., Perry M.H., Morley J.E. 2006: Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder--a pilot study. Am. J. Geriatr. Psychiatry 14: 900-910. Go to original source... Go to PubMed...
  167. Teichner G., Wagner M.T. 2004: The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia. Arch. Clin. Neuropsychol. 19: 455-464. Go to original source... Go to PubMed...
  168. Tesoriero C., Del Gallo F., Bentivoglio M. 2019: Sleep and brain infections. Brain Res. Bull. 145: 59-74. Go to original source... Go to PubMed...
  169. Theofilopoulos A.N., Kono D.H., Baccala R. 2017: The multiple pathways to autoimmunity. Nat. Immunol. 18: 716-724. Go to original source... Go to PubMed...
  170. Tombaugh T.N. 1997: The Test of Memory Malingering (TOMM): Normative data from cognitively intact and cognitively impaired individuals. Psychological. Assessment 9: 260-268. Go to original source...
  171. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. 2007: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33: 729-736. Go to original source... Go to PubMed...
  172. Torrey E.F., Bartko J.J., Yolken R.H. 2012: Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 38: 642-647. Go to original source... Go to PubMed...
  173. Trammell R.A., Toth L.A. 2014: Behavioral perturbation and sleep in healthy and virus-infected inbred mice. Comp. Med. 64: 283-292.
  174. Trier N.H., Houen G. 2023: Antibody cross-reactivity in auto-immune diseases. Int. J .Mol. Sci. 24: 13609. Go to original source... Go to PubMed...
  175. Turecki G., Brent D.A. 2016: Suicide and suicidal behaviour. Lancet 387: 1227-1239. Go to original source... Go to PubMed...
  176. U.S. Department of Veterans Affairs 2023: 2023 National Veteran suicide prevention annual report. March 18 2024 https://www.mentalhealth.va.gov/suicide_prevention/data.asp.
  177. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., Sapolsky R.M. 2007: Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. U.S.A. 104: 6442-6447. Go to original source... Go to PubMed...
  178. Wadhawan A., Dagdag A., Duffy A., Daue M.L., Ryan K.A., Brenner L.A., Stiller J.W., Pollin T.I., Groer M.W., Huang X., Lowry C.A., Mitchell B.D., Postolache T.T. 2017: Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study. Pteridines 28: 185-194. Go to original source... Go to PubMed...
  179. Weathers F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., Schnurr, P.P. 2013: The PTSD checklist for DSM-5 (PCL-5). April 10 2024 www.ptsd.va.gov.
  180. Webster J.P., Brunton C.F., MacDonald D.W. 1994: Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology 109: 37-43. Go to original source... Go to PubMed...
  181. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. 2006: Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 273: 1023-1030. Go to original source... Go to PubMed...
  182. Xiao J., Li Y., Prandovszky E., Karuppagounder S.S., Talbot Jr C.C., Dawson V.L., Dawson T.M., Yolken R.H. 2014: MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268: 128-138. Go to original source... Go to PubMed...
  183. Yolken R.H., Dickerson F.B., Fuller Torrey E. 2009: Toxoplasma and schizophrenia. Parasite Immunol. 31: 706-715. Go to original source... Go to PubMed...
  184. Zahl D.L., Hawton K. 2004: Repetition of deliberate self-harm and subsequent suicide risk: long-term follow-up study of 11,583 patients. Br. J. Psychiatry. 185: 70-75. Go to original source... Go to PubMed...
  185. Zhang L., Sander J.W., Zhang L., Jiang X.Y., Wang W., Shuang K., Abdulaziz A.T.A., Wu M.Q., Chi X.S., Li J.M., Zhou D. 2017: Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis. J. Neurol. 264: 2378-2386. Go to original source... Go to PubMed...
  186. Zhang Y., Traskman-Bendz L., Janelidze S., Langenberg P., Saleh A., Constantine N., Okusaga O., Bay-Richter C., Brundin L., Postolache T.T. 2012: Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J. Clin. Psychiatry 73: 1069-1076. Go to original source... Go to PubMed...
  187. Zhao X.Y., Ewald S.E. 2020: The molecular biology and immune control of chronic Toxoplasma gondii infection. J. Clin. Invest. 130: 3370-3380. Go to original source... Go to PubMed...